Neil Osheroff

October 30, 2023

Crowe, Osheroff honored by AAMC

Vanderbilt’s James E. Crowe, Jr, MD, and Neil Osheroff, PhD, are among 12 individuals honored by the Association of American Medical Colleges during its 2023 Awards Recognition Event.

By Bill Snyder
April 24, 2023

Novel drugs have potential for treating tuberculosis

Drug-resistant tuberculosis is on the rise, and novel antibacterial drugs called SPTs have potential for treating the deadly lung infection.

By Leigh MacMillan
February 2, 2023

Study explores new urinary tract infection treatment

Vanderbilt’s Neil Osheroff, PhD, is part of an international research collaboration resulting in what is on track to be the first new antibiotic treatment for uncomplicated urinary tract infections in more than 20 years.

By Marissa Shapiro
From left are Bonnie Miller, MD, VUMC; Odell Kumeh, MD, MPH, ULCHS; Marie Martin, PhD, MEd, VUMC; Bernice Dahn, MD, MPH, ULCHS; Kristina Talbert-Slagle, PhD, Yale; and Comfort Enders, MEd, ULCHS.
February 24, 2022

Capacity building activities and new curriculum strengthen medical education in Liberia

Liberia’s fragile health system is being strengthened through U.S.-Liberia partnerships focused on medical education and capacity building at the country’s only medical school, A.M. Dogliotti (AMD) School of Medicine in the College of Health Sciences at the University of Liberia.

By Kristin Centers
December 12, 2019

Osheroff elected IAMSE president

Neil Osheroff, PhD, was elected president of the International Association of Medical Science Educators (IAMSE) and will serve from January 2020-December 2021.

By Kathy Whitney
July 8, 2019

International Association of Medical Science Educators honors Osheroff

Neil Osheroff, PhD, John G. Coniglio professor of Biochemistry, professor of Medicine and director of the Academy for Excellence in Education, received the Distinguished Career Award for Excellence in Teaching and Educational Scholarship from the International Association of Medical Science Educators (IAMSE).

By Kathy Whitney
April 25, 2019

A new antibiotic’s mechanism of action

Vanderbilt investigators have characterized how a new first-in-class antibacterial drug works, which will guide the development of additional compounds that overcome antibacterial resistance.
By Leigh MacMillan
March 14, 2019

Correctly copying DNA

A precise understanding of how the enzyme topoisomerase II cuts DNA could lead to better anti-cancer therapies.
By Sanjay Mishra
November 29, 2018

Five faculty elected AAAS fellows

Five Vanderbilt University faculty members have been elected fellows of the American Association for the Advancement of Science this year.
By Bill Snyder
June 11, 2018

Confronting TB resistance

Vanderbilt researchers describe how certain tuberculosis treatments work and suggest these medications may overcome the threat of drug-resistant tuberculosis.
By Niyati Vachharajani
April 26, 2018

Self care, mindfulness key to decreasing burnout: speaker

It’s not often that a keynote speaker will ask his audience to close their eyes and tune him out, but that’s what Aviad “Adi” Haramati, PhD, did when delivering the 2018 John E. Chapman Lecture.
By Kathy Whitney
September 29, 2017

Novel insights to antibiotic targets

New mechanistic details about the DNA-unwinding activity of antibacterial protein targets could lead to the design of better antibiotic medicines.
By Leigh MacMillan
November 17, 2016

School of Medicine’s newest teaching award honors Nanney

Vanderbilt University School of Medicine (VUSM) recently established the Academy for Excellence in Education Lillian B. Nanney Award for Outstanding Service to the VUSM/Vanderbilt University Medical Center (VUMC) Community of Educators.
By Kathy Whitney